<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="6912530 doi: 10.3390/cells8111444cells-08-01444 : Article The Envelope Residues E152/156/158 of" exact="Zika" post="Virus Influence the Early Stages of Virus Infection in"/>
 <result pre="Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Emerging infections of mosquito-borne" exact="Zika" post="virus (ZIKV) pose an increasing threat to human health,"/>
 <result pre="structural proteins capsid (C), pre-membrane (prM), and envelop (E) of" exact="ZIKV" post="epidemic strains with the initiation of viral infection in"/>
 <result pre="C-prM region contributes to permissiveness of human host cells to" exact="ZIKV" post="infection and ZIKV-induced cytopathic effects, whereas the E protein"/>
 <result pre="and early infection. In the present study, we further characterize" exact="ZIKV" post="E proteins by investigating the roles of residues isoleucine"/>
 <result pre="site (E-154), in permissiveness of human host cells to epidemic" exact="ZIKV" post="infection. For comparison purpose, we generated mutant molecular clones"/>
 <result pre="important contribution of E-152/156/158 residues to the early steps of" exact="ZIKV" post="infection in human cells. flavivirus Zika virus envelope protein"/>
 <result pre="the early steps of ZIKV infection in human cells. flavivirus" exact="Zika" post="virus envelope protein glycosylation fusion loop viral fusion cell"/>
 <result pre="glycosylation fusion loop viral fusion cell entry 1. Introduction Mosquito-borne" exact="Zika" post="(ZIKV), dengue (DENV), Yellow fever (YFV) and Japanese encephalitis"/>
 <result pre="fusion cell entry 1. Introduction Mosquito-borne Zika (ZIKV), dengue (DENV)," exact="Yellow fever" post="(YFV) and Japanese encephalitis (JEV) viruses belonging to flavivirus"/>
 <result pre="RNA viruses of significant public health concern worldwide [1,2,3,4]. Recent" exact="ZIKV" post="global outbreaks, with Brazil at the epicentre, highlighted how"/>
 <result pre="turn into a severe threat for human health. While human" exact="ZIKV" post="infections remained only sporadic and with a limited impact"/>
 <result pre="a limited impact for decades [5,6,7,8], recent outbreaks revealed that" exact="ZIKV" post="caused clusters of severe congenital and neurological abnormalities in"/>
 <result pre="enhancement/cross-reactivity of reactive antibodies [18,19,20,21]. Recently, our studies on chimeric" exact="ZIKV" post="clones between an epidemic Brazilian strain of ZIKV BeH819015"/>
 <result pre="on chimeric ZIKV clones between an epidemic Brazilian strain of" exact="ZIKV" post="BeH819015 (hereafter called BR15) and a historical African strain"/>
 <result pre="important role of two structural proteins prM/M, and E in" exact="ZIKV" post="ability to infect human cells [16,22,23,24]. We further showed"/>
 <result pre="C-prM region plays a role in triggering cell death by" exact="ZIKV" post="and E protein is associated with viral attachment to"/>
 <result pre="position E-56 and E-154. The first site is lacking in" exact="ZIKV" post="E protein and contribution of the second site in"/>
 <result pre="ZIKV E protein and contribution of the second site in" exact="ZIKV" post="viral cycle, including in the mosquito vector, has been"/>
 <result pre="E protein was shown to be an important determinant of" exact="ZIKV" post="virulence in a mouse model of viral encephalitis [22,26]."/>
 <result pre="a mouse model of viral encephalitis [22,26]. In invertebrate vectors," exact="ZIKV" post="bearing an unglycosylated E protein was attenuated in its"/>
 <result pre="could remain unglycosylated as it has been observed in some" exact="ZIKV" post="strains. To date, the exact mechanism by which the"/>
 <result pre="the N-glycosylation motif region of the E protein contributes to" exact="ZIKV" post="infectivity still remains elusive. In the present study, we"/>
 <result pre="the present study, we further characterised structural protein contribution in" exact="ZIKV" post="infectivity by focusing on the ZIKV E protein. Our"/>
 <result pre="structural protein contribution in ZIKV infectivity by focusing on the" exact="ZIKV" post="E protein. Our goal was to determine whether three"/>
 <result pre="from Sigma-Aldrich (Saint-Louis, MO, USA). Rat antibody specifically raised against" exact="ZIKV" post="E protein Domain III was developed in-house and used"/>
 <result pre="purchased from Vector Laboratories (Burlingame, CA, USA). 2.2. Design of" exact="ZIKV" post="Molecular Clones ZIKV molecular clones (MR766, GenBank accession number"/>
 <result pre="Laboratories (Burlingame, CA, USA). 2.2. Design of ZIKV Molecular Clones" exact="ZIKV" post="molecular clones (MR766, GenBank accession number LC002520, and BR15,"/>
 <result pre="viral sequence of MR766 in which E-152/156/158 residues of BR15" exact="ZIKV" post="strain were introduced and viral sequence of BR15 in"/>
 <result pre="which E-152/156/158 residues were replaced with its counterpart from MR766" exact="ZIKV" post="strain. 2.4. Plaque-Forming Assay Viral titres were determined by"/>
 <result pre="units (PFU) per mL (PFU·mL−1). 2.5. Quantification of Viral Stocks" exact="Zika" post="virus samples were analysed by titration on Vero cells"/>
 <result pre="(Qiagen, Hilden, Germany). PCR standard curve used for quantification of" exact="ZIKV" post="copy numbers was obtained with a pUC57/ZIKV-E amplicon plasmid"/>
 <result pre="961 to 1301 of genomic RNA (MR766). The pair of" exact="ZIKV" post="E primers was used to equally amplify pUC57/ZIKV-E amplicon"/>
 <result pre="cDNA encompassing nucleotides 1046 to 1213 from genomic RNA of" exact="ZIKV" post="molecular clones used in this study. 2.6. Immunoblot Assay"/>
 <result pre="control. Primers used in this study are listed in [31]." exact="ZIKV" post="E primers were designed to match both MR766-NIID and"/>
 <result pre="2% FBS. Pre-chilled cells were incubated at 4 °C with" exact="ZIKV" post="at MOI of 1 in 1.5 mL of cold"/>
 <result pre="RT-qPCR analysis on viral RNA was performed using primers for" exact="ZIKV" post="E gene as described above. 2.10. Fusion Assay Cells"/>
 <result pre="10% FBS. Pre-chilled cells were incubated at 4 °C with" exact="ZIKV" post="at MOI of 1 in 1 mL of cold"/>
 <result pre="cells. 2.13. TMD2-M/E Expression To express recombinant E proteins from" exact="ZIKV" post="in mammalian cells, TMD2-prM (TransMembrane Domain II) and E"/>
 <result pre="La Jolla, CA, USA). 3. Results 3.1. Characterization of Mutant" exact="ZIKV" post="Molecular Clones To determine the contribution of E-152/156/158 residues"/>
 <result pre="Molecular Clones To determine the contribution of E-152/156/158 residues in" exact="ZIKV" post="E protein functions, we generated two mutant molecular clones:"/>
 <result pre="confirmed that the introduced mutations affected the electrophoretic mobility of" exact="ZIKV" post="E proteins, suggesting that E-152/156/158 residues from BR15 E"/>
 <result pre="virion infectivity. 3.3. Alteration of Residues E-152 to E-158 of" exact="ZIKV" post="E Protein Does Not Affect Virus Binding to Host"/>
 <result pre="Virus Progeny Production We previously showed that historical and epidemic" exact="ZIKV" post="strains display differences in their abilities to bind host"/>
 <result pre="data suggest that alteration of residues E-152 to E-158 of" exact="ZIKV" post="E protein does not affect virus bindings to A549-Dual™"/>
 <result pre="cells. Instead, these results suggest that E-152/156/158 residues might influence" exact="ZIKV" post="progeny production. Indeed, the progeny production of MR766E-MUT was"/>
 <result pre="we showed previously that this pathway is not activated upon" exact="ZIKV" post="infection [23]. These results indicate that differences in the"/>
 <result pre="our previous observations suggesting a link between host-cell responses and" exact="ZIKV" post="nonstructural proteins [23]. 3.5. E-152/156/158 Residues from BR15 Facilitate"/>
 <result pre="inhibition of pH-dependent steps. Recently, chloroquine was shown to inhibit" exact="Zika" post="virus infection in different cellular models [36,37]. As BR15"/>
 <result pre="differences observed between BR15 and mutant BR15 TMD2-prM/E suggested that" exact="ZIKV" post="E proteins bear different conformations that only depend on"/>
 <result pre="bearing E-152/156/158 residues from MR766. Preliminary in silico modelling of" exact="ZIKV" post="E proteins suggest that changes in the glycosylation motif"/>
 <result pre="residues in the EDI domain support conformational changes on the" exact="ZIKV" post="E protein, which could be detected in the fusion"/>
 <result pre="of structural proteins in determining infectivity of human cells to" exact="ZIKV" post="infection has been previously reported [23]. Zika viruses of"/>
 <result pre="human cells to ZIKV infection has been previously reported [23]." exact="Zika" post="viruses of historical or epidemic strains display differences in"/>
 <result pre="susceptibility to infection. To further characterise biological properties of contemporary" exact="ZIKV" post="strains, which have been associated with recent epidemics and"/>
 <result pre="E proteins [38]. Our data demonstrate that E-152/156/158 residues of" exact="ZIKV" post="E protein do not influence virus binding, which suggests"/>
 <result pre="by E-152/156/158 residues. We conclude that this initial step of" exact="ZIKV" post="entry into cells does not depend on E-152/156/158 residues"/>
 <result pre="Sevvana and colleagues proposed that, given the close proximity of" exact="ZIKV" post="glycan and fusion loops, any interaction of the glycan"/>
 <result pre="study based on antibody neutralizing activities demonstrated that residues surrounding" exact="ZIKV" post="E protein glycan regulate virus antigenicity [44]. In a"/>
 <result pre="access of the fusion loop. The role of N-glycosylation on" exact="ZIKV" post="E protein has also been investigated using pseudoviral particles,"/>
 <result pre="we demonstrated with recombinant proteins that E-152/156/158 residues of epidemic" exact="ZIKV" post="E protein also facilitate production of more soluble proteins."/>
 <result pre="[49]. All these observations suggest that E-152/156/158 residues of epidemic" exact="ZIKV" post="E protein could also be an advantage during virion"/>
 <result pre="Altogether, our data indicate that the envelope residues E152/156/158 of" exact="Zika" post="virus influence early stages of virus infection in human"/>
 <result pre="cells. This study highlights the importance of E-152/156/158 residues in" exact="ZIKV" post="biology and specifically in their roles in supporting viral"/>
 <result pre="findings could potentially help to design innovative strategies for future" exact="ZIKV" post="infection control. Acknowledgments We gratefully acknowledge Pascale Krejbich-Trotot and"/>
 <result pre="https://www.mdpi.com/2073-4409/8/11/1444/s1, Figure S1: Tunicamycin treatment of Vero cells infected with" exact="ZIKV" post="mutant molecular clones, Figure S2: structures of ZIKV E"/>
 <result pre="infected with ZIKV mutant molecular clones, Figure S2: structures of" exact="ZIKV" post="E wild-type and mutant proteins. LINK Click here for"/>
 <result pre="no conflict of interest. References References 1.LeeI.BosS.LiG.WangS.GadeaG.DesprèsP.ZhaoR.Y.Probing Molecular Insights into" exact="Zika" post="Virus–Host InteractionsViruses20181023310.3390/v1005023329724036 2.BosS.GadeaG.DespresP.Dengue: A growing threat requiring vaccine development"/>
 <result pre="Soc. Pathol. Exot. Filiales19787113114033772 9.Cao-LormeauV.-M.BlakeA.MonsS.LastèreS.RocheC.VanhomwegenJ.DubT.BaudouinL.TeissierA.LarreP.et al.Guillain-Barré Syndrome outbreak associated with" exact="Zika" post="virus infection in French Polynesia: A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 10.CugolaF.R.FernandesI.R.RussoF.B.FreitasB.C.DiasJ.L.M.GuimarãesK.P.BenazzatoC.AlmeidaN.PignatariG.C.RomeroS.et"/>
 <result pre="infection in French Polynesia: A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 10.CugolaF.R.FernandesI.R.RussoF.B.FreitasB.C.DiasJ.L.M.GuimarãesK.P.BenazzatoC.AlmeidaN.PignatariG.C.RomeroS.et al.The Brazilian" exact="Zika" post="virus strain causes birth defects in experimental modelsNature201653426727110.1038/nature1829627279226 11.MerfeldE.Ben-AviL.KennonM.CervenyK.L.Potential"/>
 <result pre="microcephalyWiley Interdiscip. Rev. Dev. Biol.2017e27310.1002/wdev.27328383800 12.ParraB.LizarazoJ.Jiménez-ArangoJ.A.Zea-VeraA.F.González-ManriqueG.VargasJ.AngaritaJ.A.ZuñigaG.Lopez-GonzalezR.BeltranC.L.et al.Guillain-Barré Syndrome Associated with" exact="Zika" post="Virus Infection in ColombiaN. Engl. J. Med.20163751513152310.1056/NEJMoa160556427705091 13.SmitJ.MoeskerB.Rodenhuis-ZybertI.WilschutJ.Flavivirus Cell"/>
 <result pre="y AlmeidaM.E.Garcia-CorderoJ.CamposF.D.Namorado-TonixK.PerezF.Serological tests reveal significant cross-reactive human antibody responses to" exact="Zika" post="and Dengue viruses in the Mexican populationActa Trop.201920110520110.1016/j.actatropica.2019.10520131562846 20.Montecillo-AguadoM.R.Montes-GómezA.E.García-CorderoJ.Corzo-GómezJ.Vivanco-CidH.Mellado-SánchezG.Muñoz-MedinaJ.E.Gutiérrez-CastañedaB.Santos-ArgumedoL.González-BonillaC.et"/>
 <result pre="tests reveal significant cross-reactive human antibody responses to Zika and" exact="Dengue" post="viruses in the Mexican populationActa Trop.201920110520110.1016/j.actatropica.2019.10520131562846 20.Montecillo-AguadoM.R.Montes-GómezA.E.García-CorderoJ.Corzo-GómezJ.Vivanco-CidH.Mellado-SánchezG.Muñoz-MedinaJ.E.Gutiérrez-CastañedaB.Santos-ArgumedoL.González-BonillaC.et al.Cross-Reaction, Enhancement,"/>
 <result pre="Mexican populationActa Trop.201920110520110.1016/j.actatropica.2019.10520131562846 20.Montecillo-AguadoM.R.Montes-GómezA.E.García-CorderoJ.Corzo-GómezJ.Vivanco-CidH.Mellado-SánchezG.Muñoz-MedinaJ.E.Gutiérrez-CastañedaB.Santos-ArgumedoL.González-BonillaC.et al.Cross-Reaction, Enhancement, and Neutralization Activity of" exact="Dengue" post="Virus Antibodies against Zika Virus: A Study in the"/>
 <result pre="al.Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against" exact="Zika" post="Virus: A Study in the Mexican PopulationJ. Immunol. Res.20192019723934710.1155/2019/723934731565661"/>
 <result pre="in the Mexican PopulationJ. Immunol. Res.20192019723934710.1155/2019/723934731565661 21.DaiL.SongJ.LuX.DengY.-Q.MusyokiA.M.ChengH.ZhangY.YuanY.SongH.HaywoodJ.et al.Structures of the" exact="Zika" post="Virus Envelope Protein and Its Complex with a Flavivirus"/>
 <result pre="Virol.201791e01348-1710.1128/JVI.01348-1728931684 23.BosS.ViranaickenW.TurpinJ.El-KalamouniC.RocheM.Krejbich-TrototP.DesprèsP.GadeaG.The structural proteins of epidemic and historical strains of" exact="Zika" post="virus differ in their ability to initiate viral infection"/>
 <result pre="cellsVirology201851626527310.1016/j.virol.2017.12.00329395111 24.LiG.BosS.TsetsarkinK.A.PletnevA.G.DesprèsP.GadeaG.ZhaoR.Y.The Roles of prM-E Proteins in Historical and Epidemic" exact="Zika" post="Virus-mediated Infection and NeurocytotoxicityViruses20191115710.3390/v11020157 25.GongD.ZhangT.-H.ZhaoD.DuY.ChapaT.J.ShiY.WangL.ContrerasD.ZengG.ShiP.-Y.et al.High-Throughput Fitness Profiling of"/>
 <result pre="Zika Virus-mediated Infection and NeurocytotoxicityViruses20191115710.3390/v11020157 25.GongD.ZhangT.-H.ZhaoD.DuY.ChapaT.J.ShiY.WangL.ContrerasD.ZengG.ShiP.-Y.et al.High-Throughput Fitness Profiling of" exact="Zika" post="Virus E Protein Reveals Different Roles for Glycosylation during"/>
 <result pre="Infection of Mammalian and Mosquito CellsiScience201819711110.1016/j.isci.2018.02.00530227960 26.CarbaughD.L.BaricR.S.LazearH.M.Envelope Protein Glycosylation Mediates" exact="Zika" post="Virus PathogenesisJ. Virol.201993e00113-1910.1128/JVI.00113-1930944176 27.Fontes-GarfiasC.R.ShanC.LuoH.MuruatoA.E.MedeirosD.B.A.MaysE.XieX.ZouJ.RoundyC.M.WakamiyaM.et al.Functional Analysis of Glycosylation of"/>
 <result pre="Zika Virus PathogenesisJ. Virol.201993e00113-1910.1128/JVI.00113-1930944176 27.Fontes-GarfiasC.R.ShanC.LuoH.MuruatoA.E.MedeirosD.B.A.MaysE.XieX.ZouJ.RoundyC.M.WakamiyaM.et al.Functional Analysis of Glycosylation of" exact="Zika" post="Virus Envelope ProteinCell Rep.2017211180119010.1016/j.celrep.2017.10.01629091758 28.ViranaickenW.NativelB.Krejbich-TrototP.HarrabiW.BosS.El KalamouniC.RocheM.GadeaG.DesprèsP.ClearColi BL21(DE3)-based expression of"/>
 <result pre="Zika Virus Envelope ProteinCell Rep.2017211180119010.1016/j.celrep.2017.10.01629091758 28.ViranaickenW.NativelB.Krejbich-TrototP.HarrabiW.BosS.El KalamouniC.RocheM.GadeaG.DesprèsP.ClearColi BL21(DE3)-based expression of" exact="Zika" post="virus antigens illustrates a rapid method of antibody production"/>
 <result pre="pathogensBiochimie201714217918210.1016/j.biochi.2017.09.01128942054 29.GadeaG.BosS.Krejbich-TrototP.ClainE.ViranaickenW.El-KalamouniC.MavinguiP.DesprèsP.A robust method for the rapid generation of recombinant" exact="Zika" post="virus expressing the GFP reporter geneVirology201649715716210.1016/j.virol.2016.07.01527471954 30.AubryF.NougairedeA.de FabritusL.QueratG.GouldE.A.de LamballerieX.Single-stranded"/>
 <result pre="subgenomic ampliconsJ. Gen. Virol.2014952462246710.1099/vir.0.068023-025053561 31.FrumenceE.RocheM.Krejbich-TrototP.El-KalamouniC.NativelB.RondeauP.MisséD.GadeaG.ViranaickenW.DesprèsP.The South Pacific epidemic strain of" exact="Zika" post="virus replicates efficiently in human epithelial A549 cells leading"/>
 <result pre="keratinocytesJ. Cell Sci.20111243568358010.1242/jcs.08405322045735 36.DelvecchioR.HigaL.PezzutoP.ValadãoA.GarcezP.MonteiroF.LoiolaE.DiasA.SilvaF.AliotaM.et al.Chloroquine, an Endocytosis Blocking Agent, Inhibits" exact="Zika" post="Virus Infection in Different Cell ModelsViruses2016832210.3390/v8120322 37.ZhangS.YiC.LiC.ZhangF.PengJ.WangQ.LiuX.YeX.LiP.WuM.et al.Chloroquine inhibits"/>
 <result pre="viral replication and effectively prevents maternal to fetal transmission of" exact="Zika" post="virusAntivir. Res.201916910454710.1016/j.antiviral.2019.10454731251958 38.ChenY.MaguireT.HilemanR.E.FrommJ.R.EskoJ.D.LinhardtR.J.MarksR.M.Dengue virus infectivity depends on envelope protein"/>
 <result pre="Rev.20153915517010.1093/femsre/fuu00425725010 40.PiersonT.C.KielianM.Flaviviruses: Braking the enteringCurr. Opin. Virol.2013331210.1016/j.coviro.2012.12.00123352692 41.LeeE.WeirR.C.DalgarnoL.Changes in the" exact="Dengue" post="Virus Major Envelope Protein on Passaging and Their Localization"/>
 <result pre="tick cellsJ. Gen. Virol.2013942249225810.1099/vir.0.055269-023824303 43.SevvanaM.LongF.MillerA.S.KloseT.BudaG.SunL.KuhnR.J.RossmannM.G.Refinement and Analysis of the Mature" exact="Zika" post="Virus Cryo-EM Structure at 3.1 Å ResolutionStructure20182611691177.e310.1016/j.str.2018.05.00629958768 44.GooL.DeMasoC.R.PelcR.S.LedgerwoodJ.E.GrahamB.S.KuhnR.J.PiersonT.C.The Zika"/>
 <result pre="Mature Zika Virus Cryo-EM Structure at 3.1 Å ResolutionStructure20182611691177.e310.1016/j.str.2018.05.00629958768 44.GooL.DeMasoC.R.PelcR.S.LedgerwoodJ.E.GrahamB.S.KuhnR.J.PiersonT.C.The" exact="Zika" post="virus envelope protein glycan loop regulates virion antigenicityVirology201851519120210.1016/j.virol.2017.12.03229304471 45.FrumenceE.ViranaickenW.GadeaG.DesprèsP.A"/>
 <result pre="Reporter MR766-Based Flow Cytometry Neutralization Test for Rapid Detection of" exact="Zika" post="Virus-Neutralizing Antibodies in Serum SpecimensVaccines201976610.3390/vaccines703006631315283 46.FrumenceE.ViranaickenW.BosS.Alvarez-MartinezM.-T.RocheM.ArnaudD.J.GadeaG.DesprèsP.A Chimeric Zika Virus"/>
 <result pre="Detection of Zika Virus-Neutralizing Antibodies in Serum SpecimensVaccines201976610.3390/vaccines703006631315283 46.FrumenceE.ViranaickenW.BosS.Alvarez-MartinezM.-T.RocheM.ArnaudD.J.GadeaG.DesprèsP.A Chimeric" exact="Zika" post="Virus between Viral Strains MR766 and BeH819015 Highlights a"/>
 <result pre="Loop in Antibody-mediated Virus NeutralizationVaccines201975510.3390/vaccines7020055 47.MossentaM.MarcheseS.PoggianellaM.Slon CamposJ.L.BurroneO.R.Role of N-glycosylation on" exact="Zika" post="virus E protein secretion, viral assembly and infectivityBiochem. Biophys."/>
 <result pre="Characterization of Flavivirus Envelope Glycoprotein Cross-Reactive EpitopesJ. Virol.200478139751398610.1128/JVI.78.24.13975-13986.200415564505 Figure 1" exact="ZIKV" post="mutant molecular clones. In (a), schematic representation of mutant"/>
 <result pre="A549-Dual™ cells. Pre-chilled cells were incubated at 4 °C with" exact="ZIKV" post="at MOI of 1. After 1-h incubation, cells were"/>
 <result pre="0.1 Figure 5 Conformational changes induced by residues E-152/156/158 of" exact="ZIKV" post="E protein. In (a) and (b), HEK-293T cells were"/>
</results>
